Anantha Shekhar, M.D., Ph.D.
|
Anantha Shekhar, M.D., Ph.D. |
||
| Personal Statement | As the director of the Indiana Clinical and Translational Sciences Institute, I lead the effort to promote IUSM research that focuses on translating discoveries in basic neurosciences into potential clinical applications to treat neuropsychiatric disorders such as panic disorder, schizophrenia, and autism. I conduct numerous foundation supported studies, including being the principal investigator of the longitudinal study of disease risk factors in Indiana population. I am also the director of the Neuroscience Clinical Research Center. | |
|---|---|---|
| Education | Undergraduate: St. Joseph's College Medical School: St. John's Medical College Graduate School: Indiana University School of Medicine Residency: Indiana University School of Medicine Fellowship: Indiana University School of Medicine Board Certifications/Certifications: American Board of Psychiatry and Neurology |
|
| Current Academic Interests | Teaching: Involved in teaching psychiatry residency and fellowship programs and in the medical neurosciences programs. Research: My basic science studies have focused on defining the neutral basis of panic disorder, social anxiety, and stress-induced emotional disorders. My translational work has focused on developing novel treatment targets for major psychiatric disordres in patients with panic disorder and schizophrenia. |
|
| Recent Publications | Shekhar A, Potter WZ, Lightfoot J, Leinneman J, McKenzie D, Bymaster F, Felder C. Selective Muscarinic Receptor Agonist Xanomeline is a Novel Treatment Approach for Schizophrenia. Am. J. Psychiatry. (2008) in press. Johnson PL, Truitt WA, Fitz SD, Keim SR, Lowry CA, Shekhar A. Neural circuits underlying panic-like response to sodium lactate. J. Neuropsychopharmacol. (2008) Jan 4. epub ahead of text. Sajdyk TJ, Johnson PL, Fitz SD, Moran M, Gehlert DR, Urban J, Shekhar A. NPY-induced synaptic plasticity results in stress resilience. J. Neurosci. (2008) 28(4):893-903. |
|

